抄録
The identification of patients with acoustic neuromas is changing due to constraints forced by escalating medical costs. Evolving diagnostic technologies are providing alternatives for well established diagnostic tools. With respect to treatment, careful retrospection has lead to a shift from the prior nearly ubiquitous surgical option to a more thoughtful approach of treatment choices. Weighing factors such as tumor size, patient age, involvement of the lateral reaches of the internal auditory canal, hearing status and the presence of other symptoms, otologists are now able to provide an individualized treatment plan best suited for each patient harboring an acoustic neuroma.